Skip to main content Accessibility help

Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study

  • Lieselotte Cloetens (a1), Willem F. Broekaert (a2), Yasmine Delaedt (a3), Frans Ollevier (a3), Christophe M. Courtin (a2), Jan A. Delcour (a2), Paul Rutgeerts (a1) and Kristin Verbeke (a1)...


The tolerance and prebiotic effect following oral intake by healthy human subjects of arabinoxylan-oligosaccharides (AXOS), produced by partial enzymic hydrolysis of the wheat fibre arabinoxlyan, were studied. A total of twenty healthy subjects participated in the present randomised, placebo-controlled cross-over study. They consumed 10 g AXOS or placebo per d each for 3 weeks with a 4-week wash-out period in between. Before and immediately after each intake period, blood samples were taken to measure haematological and clinical chemistry parameters and the subjects completed a questionnaire about gastrointestinal symptoms. Additionally, urine was collected over 48 h for analysis of p-cresol and phenol content by GC–MS, and faeces were collected over 72 h for analysis of microbiota using real-time PCR. Of the subjects, ten also performed a urine and faeces collection 2 weeks after the start of intake (during intervention). A limited number of tested blood parameters were influenced in a statistically significantly way by either AXOS or placebo intake, but these changes remained within the normal range. Blood lipids remained unchanged. AXOS had no statistically significant effect on the range of gastrointestinal symptoms, except for a mild increase in flatulence. Urinary p-cresol excretion, an indicator of protein fermentation, was significantly decreased after 2 weeks of AXOS intake. The levels of bifidobacteria were significantly increased after 2 and 3 weeks of AXOS intake as well as after 3 weeks of placebo. However, the effect of AXOS on bifidobacteria was more pronounced than that of placebo. In conclusion, AXOS are a well-tolerated prebiotic at the dose of 10 g/d. AXOS intake increases faecal bifidobacteria and reduces urinary p-cresol excretion.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study
      Available formats


Corresponding author

*Corresponding author: Dr Kristin Verbeke, fax +32 16 34 43 99, email


Hide All
1Grootaert, C, Delcour, JA, Courtin, CM, et al. (2007) Microbial metabolism and prebiotic potency of arabinoxylan oligosaccharides in the human intestine. Trends Food Sci 18, 6471.
2Gibson, GR, Probert, HM, Van Loo, J, et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259275.
3Yamada, H, Itoh, K, Morishita, Y, et al. (1993) Structure and properties of oligosaccharides from wheat bran. Cereal Food World 38, 490492.
4Courtin, CM, Swennen, K, Verjans, P, et al. (2009) Heat and pH stability of prebiotic arabinoxylooligosaccharides and fructooligosaccharides. Food Chem 112, 831837.
5Okazaki, M, Koda, H, Izumi, R, et al. (1991) In vitro digestibility and in vivo utilisation of xylobiose. J Jpn Soc Nutr Food Sci 44, 4144.
6Sanchez, JI, Marzorati, M, Grootaert, C, et al. (2009) Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem. Microbiol Biotechnol 2, 101113.
7Holloway, WD, Tasmanjones, C & Bell, E (1980) The hemicellulose component of a dietary fiber. Am J Clin Nutr 33, 260263.
8Sandberg, AS, Andersson, H, Hallgren, B, et al. (1981) Experimental model for in vivo determination of dietary fiber and its effect on the absorption of nutrients in the small intestine. Br J Nutr 45, 283294.
9Englyst, HN & Cummings, JH (1985) Digestion of the polysaccharides of some cereal food in the human small intestine. Am J Clin Nutr 42, 778787.
10Kabel, MA, Kortenhoeven, L, Schols, HA, et al. (2002) In vitro fermentability of differently substituted xylooligosaccharides. J Agric Food Chem 50, 62056210.
11Van Craeyveld, V, Swennen, K, Dornez, E, et al. (2008) Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties. J Nutr 138, 23482355.
12Courtin, CM, Swennen, K, Broekaert, WF, et al. (2008) Effects of dietary inclusion of xylooligosaccharides, arabinoxylooligosaccharides and soluble arabinoxylan on the microbial composition of caecal contents of chickens. J Sci Food Agr 888, 25172522.
13Courtin, CM, Broekaert, WF, Swennen, K, et al. (2008) Dietary inclusion of wheat bran arabinoxylooligosaccharides induces beneficial nutritional effects in chickens. Cereal Chem 85, 607613.
14Cloetens, L, Delaedt, Y, Ollevier, F, et al. (2008) The bifidogenic potential of arabinoxylo-oligosaccharides in healthy volunteers depends on the degree of polymerisation. Gastroenterology 134, A692.
15Cloetens, L, De Preter, V, Swennen, K, et al. (2008) Dose–response effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers. J Am Coll Nutr 27, 512518.
16Knuiman, JT, Hautvast, JGAG, Van Der Heyden, L, et al. (1986) A multi-centre study on completeness of urine collection in 11 European centres. I. Some problems with the use of creatinine and 4-aminobenzoic acid as markers of the completeness of collection. Hum Nutr Clin Nutr 50, 229237.
17Murakami, K, Sasaki, S, Takahashi, Y, et al. (2008) Sensitivity and specificity of published strategies using urinary creatinine to identify incomplete 24-h urine collection. Nutrition 24, 1620.
18de Loor, H, Bammens, B, Evenepoel, P, et al. (2005) Gas chromatographic–mass spectrometric analysis for measurements of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem 51, 15351538.
19Penders, J, Vinck, C, Driessen, C, et al. (2005) Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 243, 141147.
20Haarman, M & Knol, J (2005) Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 71, 23182324.
21Vanhoutte, T, De Preter, V, De Brandt, E, et al. (2006) Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol 72, 59905997.
22Yang, S, Lin, S, Kelen, GD, et al. (2002) Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial pathogens. J Clin Microbiol 40, 34493454.
23Byun, R, Nadkarni, MA, Chhour, KL, et al. (2004) Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 42, 31283136.
24Ramirez-Farias, C, Slezak, K, Fuller, Z, et al. (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101, 541550.
25Malinen, E, Kassinen, A, Rintillä, T, et al. (2003) Comparison of real-time PCR with SYBR Green I or 5′-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 149, 269277.
26Courtin, CM, Broekaert, WF, Swennen, K, et al. (2009) Occurence of arabinoxylo-oligosaccharides and arabinogalactan peptides in beer. J Am Soc Brew Chem 67, 112117.
27European Food Safety Authority (2009) Concise European Food Consumption database. (accessed 1 July 2009).
28Courtin, CM, Gelders, GG & Delcour, JA (2001) Use of two endoxylanases with different substrate selectivity for understanding arabinoxylan functionality in wheat flour breadmaking. Cereal Chem 78, 564571.
29Dornez, E, Joye, IJ, Gebruers, K, et al. (2006) Wheat kernel associated endoxylanases consist of a majority of microbial and a minority of wheat endogenous endoxylanases. J Sci Food Agric 54, 40284034.
30Van Haesendonck, IPH, Broekaert, WF, Georis, J, et al. (2008) Bread with Increased Arabinoxylo-Oligosaccharide Content. Publication no. WO08087167. Geneva: WIPO.
31Coudray, C, Bellanger, J, Castiglia-Delavaud, C, et al. (1997) Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 51, 375380.
32Van den Heuvel, EG, Muys, T, van Dokkum, W, et al. (1999) Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr 69, 544548.
33Thoma, C, Green, T & Ferguson, L (2003) Citrus pectin and oligofructose improve folate status and lower serum total homocysteine in rats. Int J Vit Nutr Res 73, 403409.
34Pompei, A, Cordisco, L, Amaretti, A, et al. (2007) Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol 73, 179185.
35Fiordaliso, M, Kok, N, Desager, JP, et al. (1995) Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins in rats. Lipids 30, 163167.
36Trautwein, EA, Rieckhoff, D & Erbersdobler, HF (1998) Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 128, 19371943.
37Beylot, M (2005) Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 93, Suppl. 1, S163S168.
38Pedersen, A, Sandstrom, B & Van Amelsvoort, JMM (1997) The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 78, 215222.
39Alliet, P, Scholtens, P, Raes, M, et al. (2007) Effects of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Nutrition 23, 719723.
40Forcheron, F & Beylot, M (2007) Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 56, 10931098.
41Na, MH & Kim, WK (2007) Effects of xylooligosaccharide intake on faecal bifidobacteria, lactic acid and lipid metabolism in Korean young women. Kor J Nutr 40, 154161.
42Chung, YC, Hsu, CK, Ko, CY, et al. (2007) Dietary intake of xylooligosaccharides improves the intestinal microbiota, fecal moisture, and pH value in the elderly. Nutr Res 27, 756761.
43Bouhnik, Y, Vahedi, K, Achour, L, et al. (1999) Short-chain fructo-oligosaccharide administration dose-dependently increases faecal bifidobacteria in healthy humans. J Nutr 129, 113116.
44Kruse, HP, Kleessen, B & Blaut, M (1999) Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 82, 375382.
45Bouhnik, Y, Raskine, L, Champion, K, et al. (2007) Prolonged administration of low-dose inulin stimulates the growth of bifidobacteria in humans. Nutr Res 27, 187193.
46Macfarlane, GT & Cummings, JH (1991) The colonic microflora, fermentation and large bowel digestive function. In The Large Intestine: Physiology, Pathophsiology and Disease, pp. 5192 [Philips, SF, Pemberton, H and Shorter, RG, editors]. New York: Raven Press.
47Hughes, R, Magee, EAM & Bingham, S (2000) Protein degradation in the large intestine: relevance to colorectal cancer. Curr Issues Intest Microbiol 1, 5158.
48Bone, E, Tamm, A & Hill, M (1976) The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 29, 14481454.
49Cloetens, L, Van Duppen, J, Broekaert, WF, et al. (2008) The effect of two different doses of arabinoxylo-oligosaccharides and oligofructose enriched inulin on the colonic ammonia metabolism in healthy volunteers. Gastroenterology 134, A693.
50McNeil, NI, Cummings, JH & James, WP (1978) Short chain fatty acid absorption by the human large intestine. Gut 19, 819822.
51Ruppin, H, Bar-Meir, S, Soergel, KH, et al. (1980) Absorption of short-chain fatty acids by the colon. Gastroenterology 78, 15001507.
52Hopkins, MJ, Sharp, R & Macfarlane, GT (2002) Variation in human intestinal microbiota with age. Dig Liv Dis 34, S12S18.
53Van Laere, K, Hartemink, R, Bosveld, M, et al. (2000) Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. J Agric Food Chem 48, 16441652.
54Louis, P & Flint, HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294, 18.
55Falony, G, Vlachou, A, Verbrugghe, K, et al. (2006) Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72, 78357841.
56Morrison, DJ, Mackay, WG, Edwards, CA, et al. (2006) Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr 96, 570577.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed